Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-24-007196
Filing Date
2024-10-17
Accepted
2024-10-17 16:05:07
Documents
1
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT sunshine_def14a.htm DEF 14A 209260
  Complete submission text file 0001683168-24-007196.txt   210577
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41282 | Film No.: 241377635
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)